Search clinical trials for: Allogeneic hemopoietic stem cell transplant

Total 3375 results

Hospital Universitario Dr. Jose E. Gonzalez

Completed

Hematopoietic Stem Cell Transplantation for the Treatment of Limb Ischemia and Diabetic Neuropathy

Diabetic Neuropathy | Limb Ischemia

Mexico
University of Miami

Temporarily not available

Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND) (EXPAND)

Stroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain Attack

United States
H. Lee Moffitt Cancer Center and Research Institute
Millennium Pharmaceuticals, Inc.

Completed

Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma

Multiple Myeloma

United States
University College, London

Unknown

Autologous Stem Cells in Achilles Tendinopathy (ASCAT)

Tendinopathy | Achilles Tendinitis | Achilles Degeneration | Achilles Tendinitis, Right Leg | Achilles Tendon Thickening | Achilles Tendinitis, Left Leg

United Kingdom
National Cancer Institute (NCI)

Active, not recruiting

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Smoldering Multiple Myeloma | Refractory Multiple Myeloma | DS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple Myeloma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Myelodysplastic-Myeloproliferative Diseases | Neuroblastoma | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease | Therapy-related Toxicity

United States
University Hospital, Basel, Switzerland
University Hospital, Geneva; University Hospital, Zürich

Completed

Cyclophosphamide and Busulfan as Conditioning Regimen Before Allogeneic HSCT

Myeloid Leukemia | Precursor Myeloid Neoplasms | Lymphoid Neoplasms

Switzerland
Centre Hospitalier Universitaire de Nice

Recruiting

Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy (APALLO)

Haematological Malignancy

France
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Malignant Neoplasm

United States
National Institute of Allergy and Infectious Diseases...

Completed

Stem Cell Transplantation to Treat Leukocyte Adhesion Deficiency

Leukocyte-Adhesion Deficiency Syndrome

United States
Johann Wolfgang Goethe University Hospital

Completed

Safety and Feasibility Study of Autologous Bone Marrow Cell Transplantation in Patients With Peripheral Arterial Occlusive Disease (PAOD)

Arterial Occlusive Diseases

Germany
City of Hope Medical Center

Recruiting

Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease

Sickle Cell Disease

United States
Stanford University

Enrolling by invitation

Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment

Immune Tolerance

United States
Ever Supreme Bio Technology Co., Ltd.

Recruiting

Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients

ST Elevation Myocardial Infarction

Taiwan
Tehran University of Medical Sciences

Completed

Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis (MS)

Multiple Sclerosis | Mesenchymal Stem Cells | Secondary-Progressive Multiple Sclerosis

Iran, Islamic Republic of
M.D. Anderson Cancer Center

Completed

Cellular Therapy With Cord Blood Cells

Lymphoma | Leukemia | Multiple Myeloma

United States
Ever Supreme Bio Technology Co., Ltd.

Recruiting

Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis (UMSC01)

Multiple Sclerosis

Taiwan
Michael A. Matthay
Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaborators

Completed

Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (START)

Acute Respiratory Distress Syndrome

United States
Anterogen Co., Ltd.

Recruiting

A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial

Crohn Disease

Korea, Republic of
Stanford University

Terminated

Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML)

Leukemia | Leukemia, Lymphocytic, Acute | Leukemia Acute Promyelocytic Leukemia (APL) | Leukemia Acute Lymphoid Leukemia (ALL) | Leukemia Chronic Myelogenous Leukemia (CML) | Leukemia Acute Myeloid Leukemia (AML) | Leukemia Chronic Lymphocytic Leukemia (CLL)

United States
Medical College of Wisconsin
Genzyme, a Sanofi Company

Completed

Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma | Bone Marrow Transplant Complications

United States
University Hospital, Bordeaux

Completed

Transplantation of Ex-vivo Expanded Cord Blood Stems Cells (GRAPA)

Malignant Haematological Disease

France
Uppsala University
Uppsala University Hospital

Active, not recruiting

Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome (ARDS-MSC-205)

COVID | ARDS, Human

Sweden
Altaco XXI, LLP
Duke University

Completed

A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction

Myocardial Infarction

Kazakhstan
Medical College of Wisconsin
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)

Lymphoma, Non-Hodgkin

United States
ReNeuron Limited

Completed

Pilot Investigation of Stem Cells in Stroke Phase II Efficacy (PISCES-II)

Cerebral Infarction | Hemiparesis | Ischaemic Stroke | Arm Paralysis

United Kingdom
Clinica Santa Clarita, Mexico

Withdrawn

Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells in Subjects With Osteoarthritis

Knee Osteoarthritis

Mexico
PT. Prodia Stem Cell Indonesia

Recruiting

Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B

Liver Cirrhoses

Indonesia
Sloan W. Rush, MD

Completed

Corneal Epithelial Stem Cells and Dry Eye Disease

Ocular Inflammation | Dry Eye | Dry Eye Syndromes | Ocular Surface Disease | Blepharitis | Ocular Discomfort

United States
M.D. Anderson Cancer Center

Completed

Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation

Lymphoma | Leukemia | Acute Lymphoblastic Leukemia | Allogeneic Haematopoietic Stem Cell Transplantation

United States
Ann & Robert H Lurie Children's Hospital of Chicago

Completed

Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors

Glioblastoma | Astrocytoma | Supratentorial Neoplasms | Rhabdoid Tumor | Pineoblastoma

United States
Beth Israel Deaconess Medical Center
Amgen

Completed

Mini Allo Stem Cell Transplantation for the Treatment of Solid Tumors (MiniSolid)

Metastatic Solid Tumor

United States
University Hospitals Cleveland Medical Center
Case Western Reserve University

Recruiting

Impact of Mesenchymal Stem Cells in Knee Osteoarthritis

Musculoskeletal Pain | Knee Osteoarthritis | Cartilage Injury | Cartilage Degeneration

United States
University of Liege

Completed

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

Hematological Malignancies

Belgium
M.D. Anderson Cancer Center

Completed

Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse... and other conditions

United States
Tigenix S.A.U.

Completed

Intralymphatic eASC Administration in Healthy Volunteers

Localized Adverse Reaction to Administration of Drug

Spain
National Institute of Blood and Marrow Transplant...

Completed

Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD

Graft Versus Host Disease

Pakistan
Joshua M Hare

Terminated

Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression (ANU)

Treatment Resistant Depression

United States
Anterogen Co., Ltd.

Active, not recruiting

Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Foot Ulcers

Diabetic Foot Ulcer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia

Recurrent Disease | Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Accelerated Phase of Disease | Chronic Phase of Disease

United States, Germany, Italy
Ohio State University Comprehensive Cancer Center
Incyte Corporation; Jazz Pharmaceuticals

Recruiting

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Secondary Acute Myeloid Leukemia | Myeloproliferative Neoplasm

United States
Anterogen Co., Ltd.

Completed

Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa

Korea, Republic of
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial

Diabetic Foot Ulcer

Korea, Republic of
ENCell

Completed

Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A

Charcot-Marie-Tooth Disease, Type IA

Korea, Republic of
Ever Supreme Bio Technology Co., Ltd.

Active, not recruiting

Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19 (UMSC01)

COVID-19 Infection

Taiwan
Andalusian Network for Design and Translation of...

Completed

Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19

Sars-CoV2

Spain
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Stem Cell Network; Ontario Institute...

Unknown

Cellular Immunotherapy for Septic Shock (CISS2)

Pathologic Processes | Sepsis | Systemic Inflammatory Response Syndrome | Inflammation | Shock | Septic Shock | Infection
Instituto de Investigación Sanitaria de la Fundación...
Effice Servicios Para la Investigacion S.L.

Recruiting

Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease (MEIC)

Crohn Disease | Stenosis; Bowel

Spain
Medical College of Wisconsin
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) (RICHI)

Chronic Granulomatous Disease | Hemophagocytic Lymphohistiocytosis | Leukocyte Adhesion Deficiency | Chronic Active Epstein-Barr Virus Infection | HIGM-1 | IPEX

United States, Canada

Search clinical trials for: Allogeneic hemopoietic stem cell transplant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations